Search

Author/Creator Smit, E F

3. Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers. (21st March 2019)

Authors:
Trebeschi, S; Drago, S G; Birkbak, N J; Kurilova, I; Cǎlin, A M; Delli Pizzi, A; Lalezari, F; Lambregts, D M J; Rohaan, M W; Parmar, C; Rozeman, E A; Hartemink, K J; Swanton, C; Haanen, J B A G; Blank, C U; Smit, E F; Beets-Tan, R G H; Aerts, H J W L
Journal:
Annals of oncology
Issue:
Volume 30:Number 6(2019)
Page Start:
998
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project. (23rd November 2017)

Authors:
Kerr, K M; Dafni, U; Schulze, K; Thunnissen, E; Bubendorf, L; Hager, H; Finn, S; Biernat, W; Vliegen, L; Losa, J H; Marchetti, A; Cheney, R; Warth, A; Speel, E -J; Blackhall, F; Monkhorst, K; Jantus Lewintre, E; Tischler, V; Clark, C; Bertran-Alamillo, J
Journal:
Annals of oncology
Issue:
Volume 29:Number 1(2018)
Page Start:
200
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. LBA61Phase II results for single-agent nazartinib (EGF816) in adult patients (pts) with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC). (23rd October 2018)

Authors:
Tan, D S; Kim, S-W; Sequist, L V; Ponce Aix, S; Smit, E F; Hida, T; Yang, J C-H; Felip, E; Seto, T; Grohe, C; Wolf, J; Ko, J; Marriere, E; Belli, R; Giovannini, M; Kim, D-W
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗